Inhibitory effect of adefovir on viral DNA synthesis and covalently closed circular DNA formation in duck hepatitis B virus-infected hepatocytes in vivo and in vitro

被引:77
作者
Delmas, J
Schorr, O
Jamard, C
Gibbs, C
Trépo, C
Hantz, O
Zoulim, F
机构
[1] INSERM Unit 271, F-69003 Lyon, France
[2] Gilead Sci, Foster City, CA USA
关键词
D O I
10.1128/AAC.46.2.425-433.2002
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The elimination of viral covalently closed circular DNA (CCC DNA) from the nucleus of infected hepatocytes is an obstacle to achieving sustained viral clearance during antiviral therapy of chronic hepatitis B virus (HBV) infection. The aim of our study was to determine whether treatment with adefovir, a new acyclic nucleoside phosphonate, the prodrug of which, adefovir dipivoxil, is in clinical evaluation, is able to suppress viral CCC DNA both in vitro and in vivo using the duck HBV (DHBV) model. First, the effect of adefovir on viral CCC DNA synthesis was examined with primary cultures of DHBV-infected fetal hepatocytes. Adefovir was administered for six consecutive days starting one day before or four days after DHBV inoculation. Dose-dependent inhibition of both vision release in culture supernatants and synthesis of intracellular viral DNA was observed. Although CCC DNA amplification was inhibited by adefovir, CCC DNA was not eliminated by antiviral treatment and the de novo formation of CCC DNA was not prevented by pretreatment of the cells. Next, preventive treatment of experimentally infected ducklings with lamivudine or adefovir revealed that both efficiently suppressed viremia and intrahepatic DNA. However, persistence of viral DNA even when detectable only by PCR was associated with a recurrence of viral replication following drug withdrawal. Taken together, our results demonstrate that adefovir is a potent inhibitor of DHBV replication that inhibits CCC DNA amplification but does not effectively prevent the formation of CCC DNA from incoming viral genomes.
引用
收藏
页码:425 / 433
页数:9
相关论文
共 50 条
[11]   Lamivudine as initial treatment for chronic hepatitis B in the United States [J].
Dienstag, JL ;
Schiff, ER ;
Wright, TL ;
Perrillo, RP ;
Hann, HWL ;
Goodman, Z ;
Crowther, L ;
Condreay, LD ;
Woessner, M ;
Rubin, M ;
Brown, NA .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (17) :1256-1263
[12]   Molecular anatomy and pathophysiologic implications of drug resistance in hepatitis B virus infection [J].
Doo, E ;
Liang, TJ .
GASTROENTEROLOGY, 2001, 120 (04) :1000-1008
[13]   APPLICATION OF THE NEUTRAL RED ASSAY (NR ASSAY) TO MONOLAYER-CULTURES OF PRIMARY HEPATOCYTES - RAPID COLORIMETRIC VIABILITY DETERMINATION FOR THE UNSCHEDULED DNA-SYNTHESIS TEST (UDS) [J].
FAUTZ, R ;
HUSEIN, B ;
HECHENBERGER, C .
MUTATION RESEARCH, 1991, 253 (02) :173-179
[14]   EVIDENCE THAT HEPATOCYTE TURNOVER IS REQUIRED FOR RAPID CLEARANCE OF DUCK HEPATITIS-B VIRUS DURING ANTIVIRAL THERAPY OF CHRONICALLY INFECTED DUCKS [J].
FOUREL, I ;
CULLEN, JM ;
SAPUTELLI, J ;
ALDRICH, CE ;
SCHAFFER, P ;
AVERETT, DR ;
PUGH, J ;
MASON, WS .
JOURNAL OF VIROLOGY, 1994, 68 (12) :8321-8330
[15]   Characterization of novel human hepatoma cell lines with stable hepatitis B virus secretion for evaluating new compounds against lamivudine- and penciclovir-resistant virus [J].
Fu, L ;
Cheng, YC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (12) :3402-3407
[16]   A placebo-controlled phase I/II study of adefovir dipivoxil in patients with chronic hepatitis B virus infection [J].
Gilson, RJC ;
Chopra, KB ;
Newell, AM ;
Murray-Lyon, IM ;
Nelson, MR ;
Rice, SJ ;
Tedder, RS ;
Toole, J ;
Jaffe, HS ;
Weller, IVD .
JOURNAL OF VIRAL HEPATITIS, 1999, 6 (05) :387-395
[17]   Viral clearance without destruction of infected cells during acute HBV infection [J].
Guidotti, LG ;
Rochford, R ;
Chung, J ;
Shapiro, M ;
Purcell, R ;
Chisari, FV .
SCIENCE, 1999, 284 (5415) :825-829
[18]   Apoptosis and regeneration of hepatocytes during recovery from transient hepadnavirus infections [J].
Guo, JT ;
Zhou, H ;
Liu, C ;
Aldrich, C ;
Saputelli, J ;
Whitaker, T ;
Barrasa, MI ;
Mason, WS ;
Seeger, C .
JOURNAL OF VIROLOGY, 2000, 74 (03) :1495-1505
[19]   INHIBITORY EFFECT OF 9-(2-PHOSPHONYLMETHOXYETHYL)-ADENINE (PMEA) ON HUMAN AND DUCK HEPATITIS-B VIRUS-INFECTION [J].
HEIJTINK, RA ;
DEWILDE, GA ;
KRUINING, J ;
BERK, L ;
BALZARINI, J ;
DECLERCQ, E ;
HOLY, A ;
SCHALM, SW .
ANTIVIRAL RESEARCH, 1993, 21 (02) :141-153
[20]   INHIBITORY EFFECTS OF ACYCLIC NUCLEOSIDE PHOSPHONATES ON HUMAN HEPATITIS-B VIRUS AND DUCK HEPATITIS-B VIRUS-INFECTIONS IN TISSUE-CULTURE [J].
HEIJTINK, RA ;
KRUINING, J ;
DEWILDE, GA ;
BALZARINI, J ;
DECLERCQ, E ;
SCHALM, SW .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (09) :2180-2182